Lilly Wins Bid To Shift Zyprexa Whistleblower Suit
After months of fighting, Eli Lilly & Co. has won its bid to combine a California whistleblower case alleging it marketed its blockbuster anti-psychotic drug Zyprexa for off-label uses with a...To view the full article, register now.
Already a subscriber? Click here to view full article